日本の血漿分画市場レポート：製品、セクター、用途、エンドユーザー、地域別、2025年～2033年

日本の血漿分画市場規模は2024年に9億290万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに17億230万米ドルに達し、2025年から2033年にかけて6.7%の成長率（CAGR）を示すと予測しています。現地の血漿資源を安全に利用するために、費用対効果の高いウイルス不活化技術を導入しようとする政府機関の注目が高まっていることが、主に市場成長の原動力となっています。

本レポートで扱う主な質問

• 日本の血漿分画市場はこれまでどのように推移し、今後どのように推移するのか？
• COVID-19が日本の血漿分画市場に与えた影響は？
• 日本の血漿分画市場の製品別区分は？
• 日本の血漿分画市場の分野別区分は？
• 日本の血漿分画市場の用途別区分は？
• 日本の血漿分画市場のエンドユーザー別の区分は？
• 日本の血漿分画市場のバリューチェーンにおける様々なステージとは？
• 日本の血漿分画の主要な促進要因と課題は何か？
• 日本の血漿分画市場の構造と主要企業は？
• 日本の血漿分画市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 日本の血漿分画市場-イントロダクション

• 概要
• 市場力学
• 業界動向
• 競合情報

第5章 日本の血漿分画市場情勢

• 過去および現在の市場動向（2019年～2024年）
• 市場予測（2025年～2033年）

第6章 日本の血漿分画市場- 製品別内訳

• 免疫グロブリン
• アルブミン
• 凝固因子VIII
• 凝固因子IX

第7章 日本の血漿分画市場- セクター別内訳

• 民間部門
• 公共部門

第8章 日本の血漿分画市場- 用途別の内訳

• 神経学
• 免疫学
• 血液学
• その他

第9章 日本の血漿分画市場- エンドユーザー別内訳

• 病院と診療所
• 臨床研究ラボ
• 学術機関

第10章 日本の血漿分画市場-競合情勢

• 概要
• 市場構造
• 市場企業のポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第11章 主要企業のプロファイル

第12章 日本の血漿分画市場- 業界分析

• 促進要因・抑制要因・機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第13章 付録

Japan plasma fractionation market size reached USD 902.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,702.3 Million by 2033, exhibiting a growth rate (CAGR) of 6.7% during 2025-2033. The rising focus among government bodies to introduce cost-effective viral inactivation technologies to safely utilize local plasma resources is primarily driving the market growth.

Plasma fractionation is the process of converting donated plasma into crucial life-saving treatments and medical products. It involves the division of plasma into individual proteins or plasma fractions through mechanical separation techniques like centrifugation, depth filtration, precipitation, and chromatography. In contemporary fractionation processes, various methods including alcohol concentrations, time, temperature, and pH adjustments are employed to isolate particular therapeutic proteins. Furthermore, the advancement of technology complexity over time and the implementation of viral reduction treatments during the manufacturing process have led to the emergence of novel protein therapies and enhancements in the purity and quality of products.

Japan Plasma Fractionation Market Trends:

Protein products derived from human plasma constitute a vital category of therapies extensively employed for the prevention, management, and treatment of life-threatening conditions, encompassing infections, congenital deficiencies, rare blood disorders, immunologic ailments, and autoimmune disorders. A significant upsurge in the prevalence of these conditions within a substantial portion of the population serves as a primary driver underpinning market expansion. Furthermore, manufacturers are incorporating added safety features into plasma fractionation procedures in response to stringent regulations and quality control measures mandated by regulatory agencies in numerous countries, which is positively influencing the regional market. Additionally, market stakeholders are directing financial resources towards research and development (R&D) initiatives aimed at advancing plasma production technology, thereby acting as significant growth-inducing factors. These endeavors aim to enhance product effectiveness and boost the recovery of immunoglobulin G (IgG) for the isolation of novel plasma proteins. Furthermore, they are focusing on developing cost-effective viral inactivation and processing technologies that enable the safe utilization of local plasma resources. This, in combination with the growing imperative to optimize yield, maintain process cost-efficiency, and comply with increasingly stringent regulatory standards, is poised to create a favorable market outlook in the forthcoming years.

Japan Plasma Fractionation Market Segmentation:

Product Insights:

• Immunoglobulins
• Albumin
• Coagulation Factor VIII
• Coagulation Factor IX

Sector Insights:

• Private Sector
• Public Sector

Application Insights:

• Neurology
• Immunology
• Hematology
• Others

End User Insights:

• Hospitals and Clinics
• Clinical Research Laboratories
• Academic Institutes

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan plasma fractionation market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan plasma fractionation market?
• What is the breakup of the Japan plasma fractionation market on the basis of product?
• What is the breakup of the Japan plasma fractionation market on the basis of sector?
• What is the breakup of the Japan plasma fractionation market on the basis of application?
• What is the breakup of the Japan plasma fractionation market on the basis of end user?
• What are the various stages in the value chain of the Japan plasma fractionation market?
• What are the key driving factors and challenges in the Japan plasma fractionation?
• What is the structure of the Japan plasma fractionation market and who are the key players?
• What is the degree of competition in the Japan plasma fractionation market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Plasma Fractionation Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Plasma Fractionation Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Plasma Fractionation Market - Breakup by Product

• 6.1 Immunoglobulins
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Albumin
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Coagulation Factor VIII
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Coagulation Factor IX
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)

7 Japan Plasma Fractionation Market - Breakup by Sector

• 7.1 Private Sector
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Public Sector
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)

8 Japan Plasma Fractionation Market - Breakup by Application

• 8.1 Neurology
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Immunology
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Hematology
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)
• 8.4 Others
  • 8.4.1 Historical and Current Market Trends (2019-2024)
  • 8.4.2 Market Forecast (2025-2033)

9 Japan Plasma Fractionation Market - Breakup by End User

• 9.1 Hospitals and Clinics
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2019-2024)
  • 9.1.3 Market Forecast (2025-2033)
• 9.2 Clinical Research Laboratories
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2019-2024)
  • 9.2.3 Market Forecast (2025-2033)
• 9.3 Academic Institutes
  • 9.3.1 Overview
  • 9.3.2 Historical and Current Market Trends (2019-2024)
  • 9.3.3 Market Forecast (2025-2033)

10 Japan Plasma Fractionation Market - Competitive Landscape

• 10.1 Overview
• 10.2 Market Structure
• 10.3 Market Player Positioning
• 10.4 Top Winning Strategies
• 10.5 Competitive Dashboard
• 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

• 11.1 Company A
  • 11.1.1 Business Overview
  • 11.1.2 Services Offered
  • 11.1.3 Business Strategies
  • 11.1.4 SWOT Analysis
  • 11.1.5 Major News and Events
• 11.2 Company B
  • 11.2.1 Business Overview
  • 11.2.2 Services Offered
  • 11.2.3 Business Strategies
  • 11.2.4 SWOT Analysis
  • 11.2.5 Major News and Events
• 11.3 Company C
  • 11.3.1 Business Overview
  • 11.3.2 Services Offered
  • 11.3.3 Business Strategies
  • 11.3.4 SWOT Analysis
  • 11.3.5 Major News and Events
• 11.4 Company D
  • 11.4.1 Business Overview
  • 11.4.2 Services Offered
  • 11.4.3 Business Strategies
  • 11.4.4 SWOT Analysis
  • 11.4.5 Major News and Events
• 11.5 Company E
  • 11.5.1 Business Overview
  • 11.5.2 Services Offered
  • 11.5.3 Business Strategies
  • 11.5.4 SWOT Analysis
  • 11.5.5 Major News and Events

12 Japan Plasma Fractionation Market - Industry Analysis

• 12.1 Drivers, Restraints, and Opportunities
  • 12.1.1 Overview
  • 12.1.2 Drivers
  • 12.1.3 Restraints
  • 12.1.4 Opportunities
• 12.2 Porters Five Forces Analysis
  • 12.2.1 Overview
  • 12.2.2 Bargaining Power of Buyers
  • 12.2.3 Bargaining Power of Suppliers
  • 12.2.4 Degree of Competition
  • 12.2.5 Threat of New Entrants
  • 12.2.6 Threat of Substitutes
• 12.3 Value Chain Analysis

13 Appendix